A study by Margonis et al. [39] showed that, in CRLM patients with KRAS mutations, surgical resection reduced the risk of recurrence and prolonged DFS, whereas patients with KRAS wild-type tumor did not benefit from surgical resection. The gene discussed is KRAS; the disease is neoplasm.